PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.56
-1.86 (-0.79%)
AAPL  286.40
+0.21 (0.07%)
AMD  217.52
+2.28 (1.06%)
BAC  53.76
+0.57 (1.07%)
GOOG  318.51
+2.49 (0.79%)
META  643.68
-3.42 (-0.53%)
MSFT  481.79
-8.21 (-1.68%)
NVDA  181.32
-0.14 (-0.08%)
ORCL  203.40
+2.30 (1.14%)
TSLA  443.66
+14.42 (3.36%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.